A Study to Evaluate the Safety, Tolerability and PK of SK-09
Clinical trial NCT07267026 · RECRUITING
Trial details
- NCT number
- NCT07267026
- Sponsor
- Consun Pharmaceutical Group
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-08
- Primary completion
- 2026-10-04
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.